Personalized Medicine: Cost Prohibitive or Cost Preventive?

Advances and constraints in the space of personalized medicine were the key topics at the Seventh Annual Personalized Medicine Conference at Harvard Medical School in November 2011. Michaela Miller, Vice President of the Consulting Group at Decision Resources, summarizes some of the key topics discussed at the conference in this white paper.

Please fill out the following form to get your free copy:

*First Name:
*Last Name:
*Job Title:
*Email Address:
I have read and agree to abide by the Decision Resources Terms of Use and Privacy Policy.


Search Reports

Decision Resources Group brands include: